Early stage BC and Zometa trial results
 

Conclusions after 5 years (3 years of treatment):

http://headandneckca.asco.org/ASCO/N...eutersid=10705

"It's also worth noting, Dr. Gnant said, that "the overall outcome of patients in this trial was excellent; this is reassuring that low- and intermediate-risk breast cancer patients with endocrine-responsive disease, even in the premenopause, can be safely treated without adjuvant chemotherapy," he concluded."
<!-- / message -->

I had not seen this report, but my onc told me about it Friday. I was fortunate to start Zometa early in my treatment for osteopenia. Its wonderful to hear it also reduces recurrance.

Alaska Angel, this is a very interesting article. I am going to look into this, esp since I do have osteopenia and am on Fosomax.